Pediatric and adolescent oncofertility : best practices and emerging technologies / Teresa K. Woodruff, Yasmin C. Gosiengfiao, editors.
Woodruff, Teresa K.; Gosiengfiao, Yasmin C.
2017
RC281.C4
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Pediatric and adolescent oncofertility : best practices and emerging technologies / Teresa K. Woodruff, Yasmin C. Gosiengfiao, editors.
ISBN
9783319329734 (electronic book)
3319329731 (electronic book)
9783319329710
DOI
https://doi.org/10.1007/978-3-319-32973-4
Publication Details
Cham : Springer, 2017.
Language
English
Description
1 online resource (304 pages)
Item Number
10.1007/978-3-319-32973-4 doi
Call Number
RC281.C4
Dewey Decimal Classification
618.92994
Summary
Reflecting the increasing interest in fertility management for pediatric and adolescent patients and fulfilling an urgent need to have a comprehensive guide to the management of these individuals, this is the first book of its kind to present a comprehensive discussion of pediatric and adolescent oncofertility. It carefully examines the impact of pediatric cancer and cancer therapy on fertility and presents both current and emerging fertility preservation techniques for both males and females, such as cryopreservation. Fertility concerns beyond cancer are also discussed, including disorders of sexual differentiation, gender dysphoria and thalassemia. Practical chapters on pediatric oncofertility in the clinic round out the book, covering setting up a practice, counseling and consent, disclosure and insurance considerations. Concluding chapters document fertility preservation techniques and outcomes internationally, with contributions from Portuguese, Brazilian and Japanese authors. Timely and wide-ranging, Pediatric and Adolescent Oncofertility is an ideal resource for reproductive medicine specialists, pediatric oncologists, and primary care physicians treating pediatric and adolescent cancer patients looking to protect fertility options.
Note
Nonhuman Primate Models ofßOvarian Tissue Vitrification.
Includes index.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Source of Description
Description based on print version record.
Added Author
Woodruff, Teresa K.
Gosiengfiao, Yasmin C.
Available in Other Form
Pediatric and Adolescent Oncofertility : Best Practices and Emerging Technologies.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Preface; Contents; Contributors; Chapter 1: Fertility Risk withßCancer Therapy; Introduction; Estimating Risk; Males; Females; Minimizing Risk; Gonadotropin-Releasing Hormone Agonist; Imatinib; Bone Marrow-Derived Mesenchymal Stem Cells; Sphingosine-1-phosphate (S1P); Tamoxifen; AS101; Granulocyte Colony-Stimulating Factor (G-CSF); Conclusion; References; Chapter 2: Fertility Preservation Options forßFemale Pediatric andßAdolescent Oncology Patients; Introduction; Protection ofßOvarian Function; Ovarian Transposition; Ovarian Suppression; Assisted Reproductive Endocrinology.

Embryo andßOocyte Cryopreservation Ovarian Tissue Cryopreservation andßTransplantation; Assessment ofßOvarian Reserve; Reproductive Options Post Therapy; Donor Oocytes andßEmbryos; Fertility Preservation Post Therapy; Gestational Carrier; Adoption; Access toßFertility Preservation; Ethical Considerations; Future Directions; Generation ofßGametes fromßSomatic Cells; Coverage ofßFertility Preservation by Insurance; Conclusion; References; Chapter 3: Assessing Ovarian Reserve; Background; Assessing Ovarian Reserve; Menstrual Cycles; Antral Follicle Counts andßOvarian Volume.

Endocrine Hormones Follicle-Stimulating Hormone (FSH), Inhibin B, andßEstradiol; Anti-Mullerian Hormone (AMH); Current Data onßAMH inßChildren Receiving Cancer Therapy; Ovarian Reserve Testing asßaßPredictor ofßMenstrual Pattern andßFertility; Effect ofßFemale Hormones onßOvarian Reserve Testing; References; Chapter 4: Contraception andßMenstrual Suppression forßAdolescent andßYoung Adult Oncology Patients; Contraception; Survivors; Menstrual Regulation andßSuppression; GnRH Agonist; Progestin-Only Pills; Depot Medroxyprogesterone Acetate.

Combined Hormonal Contraception (Pill, Patch, Ring) Levonorgestrel IUD forßMenstrual Suppression; Appendix: Medical Eligibility Criteria forßContraceptive Use; References; Chapter 5: Female Sexual Function inßChildhood, Adolescent, andßYoung Adult Cancer Survivors; Scope ofßtheßProblem; Barriers toßCare; Sexual Development; Infancy andßChildhood; Preadolescence; Adolescence; Sexual Development inßSurvivors ofßChildhood Cancer; Risk Factors forßSexual Dysfunction; Long-Term andßLate Effects ofßCancer Treatment onßSexual Functioning; Physiologic Effects; Psychosocial Effects.

Social Effects Female Sexual Dysfunction; Female Sexual Interest/Arousal Disorder (FSIAD); Female Orgasmic Disorder; Genito-pelvic Pain/Penetration Disorder (GPPPD); Screening andßAssessment; Treatment; Education andßSetting ofßExpectations; Non-pharmacologic Therapies; Pharmacologic Therapies; When toßRefer; Conclusion; References; Chapter 6: Vitrification ofßOvarian Tissue forßFertility Preservation; Introduction; Vitrification: Facts andßFallacies; Development ofßOvarian Tissue Vitrification Based onßCryobiological Principles; Endpoints ofßVitrification Success.

Browse Subjects

Show more subjects...

Statistics

from
to
Export